Clinical trial
Comparison of High-Dose Methotrexate (HDM) Plus Doxorubicin to HDM Plus…
NCT00180908 · Gustave Roussy, Cancer Campus, Grand Paris, Other · Completed
Key facts
| NCT number | NCT00180908 |
|---|---|
| Title | Comparison of High-Dose Methotrexate (HDM) Plus Doxorubicin to HDM Plus Etoposide-Ifosfamide in Osteosarcoma Children |
| Official title | SFOP-OS94: Multicentric Randomised Phase III Trial Comparing Efficacy of Preoperative High-Dose Methotrexate Plus Doxorubicin to Efficacy of High-Dose Methotrexate Plus Etoposide and Ifosfamide, in Children and Adolescents Osteosarcoma |
| Lead sponsor | Gustave Roussy, Cancer Campus, Grand Paris, Other |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Osteosarcoma, Localised High Grade Osteosarcoma of the Limbs |
| Intervention type | Drug |
| Interventions | Etoposide, Ifosfamide, Methotrexate, Doxorubicin |
| Enrollment | 226 |
| Start date | Jun 1, 1994 |
| First posted | Sep 16, 2005 |
| Last update posted | Sep 16, 2005 |
| Countries | France |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: